Lack of associations between thyroid dysfunction and obstructive sleep apnea-hypopnea syndrome: A meta-analysis

Juan Xiong,Hongxia Hu,Yuanyuan Huang,Jiexi Zhang,Jie He
DOI: https://doi.org/10.1097/md.0000000000036531
IF: 1.6
2024-02-23
Medicine
Abstract:Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a prevalent sleep disorder marked by recurrent, partial, or complete episodes of breathing pauses owing to an obstruction of the upper airway during sleep, thereby causing intermittent low blood oxygen saturation. [ 1 , 2 ] Globally, there are close to one billion individuals with OSAHS, with China having the highest number, followed by the United States, Brazil, and other countries. [ 3 ] Recent data depict the prevalence of moderate to severe OSAHS as 49.7% in males and 23.4% in females, with an apnea-hypopnea index (AHI) of 15 events every hour as the standard. [ 4–6 ] Typical clinical symptoms of OSAHS include recurrent sudden awakenings, morning headaches, increased nocturia, snoring during sleep, and daytime sleepiness. [ 7 ] Nevertheless, individuals often overlook these symptoms and lack effective time management techniques. OSAHS is also a comprehensive syndrome related to endocrine and metabolic complications, thereby severely impacting the survival and quality of life for individuals with OSAHS. Previous studies have shown that OSAHS is a significant independent factor for hypertension, diabetes, dyslipidemia, coronary heart disease and other diseases. [ 8 , 9 ]
medicine, general & internal
What problem does this paper attempt to address?